NEU 3.48% $13.33 neuren pharmaceuticals limited

ROW Rights, page-113

  1. 6,149 Posts.
    lightbulb Created with Sketch. 1640
    Dolor, I do not think you are on the mark by saying

    'ACAD have already committed to hefty long term payments of $400+mill's

    Under the current scenario should Rett's P3 fail only (say) $100m of that is at risk - many milestones and royalties would total zero. Should they succeed with a takeover then they would lose a lot more than that. It  is all a matter of risk vs reward assessment.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.33
Change
-0.480(3.48%)
Mkt cap ! $1.703B
Open High Low Value Volume
$13.82 $13.91 $13.32 $4.989M 369.3K

Buyers (Bids)

No. Vol. Price($)
1 500 $13.32
 

Sellers (Offers)

Price($) Vol. No.
$13.41 1680 2
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.